During the past decade, Centre Alexis Vautrin conducted 184 clinical trials. In the 10-year time frame, 184 clinical trials started and 25 clinical trials were completed, i.e. on average, 13.6% percent of trials that started reached the finish line to date. In the past 5 years, 63 clinical trials started and 9 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Alexis Vautrin" #1 sponsor was "UNICANCER" with 76 trials, followed by "Institut de Cancérologie de Lorraine" with 43 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 24 trials sponsored, "Centre Leon Berard" with 23 trials sponsored and "Hoffmann-La Roche" with 23 trials sponsored. Other sponsors include 155 different institutions and companies that sponsored additional 72 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Alexis Vautrin" #1 collaborator was "National Cancer Institute, France" with 19 trials as a collaborator, "AstraZeneca" with 9 trials as a collaborator, "UNICANCER" with 7 trials as a collaborator, "Merck Sharp & Dohme LLC" with 6 trials as a collaborator and "Roche Pharma AG" with 6 trials as a collaborator. Other collaborators include 175 different institutions and companies that were collaborators in the rest 132 trials.

According to Clinical.Site data, the most researched conditions in "Centre Alexis Vautrin" are "Breast Cancer" (50 trials), "Ovarian Cancer" (22 trials), "Prostate Cancer" (15 trials), "Colorectal Cancer" (11 trials) and "Cancer" (9 trials). Many other conditions were trialed in "Centre Alexis Vautrin" in a lesser frequency.

Most popular intervention types in "Centre Alexis Vautrin" are "Drug" (212 trials), "Other" (73 trials), "Radiation" (62 trials), "Procedure" (56 trials) and "Biological" (28 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (21 trials), "fluorouracil" (20 trials), "Placebo" (18 trials), "cisplatin" (16 trials) and "Carboplatin" (12 trials). Other intervention names were less common.

The vast majority of trials in "Centre Alexis Vautrin" are 218 trials for "All" genders, 106 trials for "Female" genders and 23 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Alexis Vautrin". 1 are not yet recruiting, 82 are recruiting, 59 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 161 completed trials in Centre Alexis Vautrin, 1 suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Alexis Vautrin, 9 "Phase 1" clinical trials were conducted, 104 "Phase 2" clinical trials and 113 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 83 trials that are defined as “Not Applicable".